Fritextsökning
Innehållstyper
-
"Djupinlärning är inte magi"
Det är inte magi men det handlar om mer än att kunna känna igen katter på internet, säger Peter Kasson vid Uppsala universitet. Han använder deep learning i sin...
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.
-
Infidelity produces faster sperms
Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
Samuel Lagercrantz: Se upp också med de fina tidskrifterna
Kvalitet och anseende går inte alltid hand i hand. Samuel Lagercrantz skriver om högstatustidskrifter och hype i journalistik och vetenskap.
-
Unika labb får miljonanslag
203 miljoner kronor har fördelats på ett flertal svenska labb.
-
Future drugs from Amaryllis
A Danish research team has discovered possibolities to extract drugs fro Amaryllis.
-
Bring talent to those in need
Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.
-
Facebookanvändare har mer hjärnminne
Personer som har många vänner på Facebook har också en större amygdala, den del av hjärnan som hanterar minne och känslor. Det visar en ny studie.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Vattenfall is firing with biomass
Vattenfall will provide Denmark with electricity by means of biomass.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Vill satsa på skräddarsydd medicin
USA:s president startar ett initiativ för personalized medicine.
-
Recipharm kammar hem entreprenörtitel
Lars Backsell och Thomas Eldered representerar Stockholm i Sverigefinalen.
-
Hennes tweet sänker börsen
Hillary Clinton föreslår nya tag mot skenande läkemedelspriser.
-
Astrazeneca i nytt bioinformatiksamarbete
Använder data från kliniska studier för att individanpassa behandlingen av cancerpatienter.
-
Bio engineering breakthrough in Denmark
Brand new research makes BioGasol's cellulosic ethanol process even more competitive.
-
Uppsving för Pandemifonden: ”Förut ville ingen lyssna”
Virologiprofessorn Niklas Arnberg pratar om smittspridning, punk och vaccinskepticism med Life Science Sweden, men framförallt om Pandemifonden som ska få Sveri...
BREAKING